Nature Communications · 2024 · 18 citations · 73 references
MedicineHematologyMolecular BiologyGene ExpressionGene TherapyHemostasisCoagulation AbnormalitiesCoagulation CascadeCoagulation Factor DeficienciesCoagulation PhysiologyHemostasis DisordersActivated Protein C ResistanceAdeno-associated Viral TransgenesisFactor Viii ActivationFactor Viii AlterationsHemostasis ModulationHemostatic RegulationProtein C Pathway ImpairmentStable Expression
Durable factor VIII expression that normalizes hemostasis is an unrealized goal of hemophilia A adeno-associated virus-mediated gene therapy. Trials with initially normal factor VIII activity observed unexplained year-over-year declines in expression while others reported low-level, stable expression inadequate to restore normal hemostasis. Here we demonstrate that male mice recapitulate expression-level-dependent loss of factor VIII levels due to declines in vector copy number. We show that an enhanced function factor VIII variant (factor VIII-R336Q/R562Q), resistant to activated protein C-mediated inactivation, normalizes hemostasis at below-normal expression without evidence of prothrombotic risk in male hemophilia A mice. These data support that factor VIII-R336Q/R562Q may restore normal factor VIII function at low levels of expression to permit durability using low vector doses to minimize dose-dependent adeno-associated virus toxicities. This work informs the mechanism of factor VIII durability after gene transfer and supports that factor VIII-R336Q/R562Q may safely overcome current hemophilia A gene therapy limitations. A major limitation in hemophilia A gene therapy is the progressive loss of factor VIII expression. Here, the authors demonstrate that low-level expression of a gain-of-function factor VIII variant may safely restore normal hemostasis and permit durability of expression.
73
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
Effect of Genome Size on AAV Vector Packaging
Zhijian Wu, Hongyan Yang, Peter Colosi · Molecular Therapy · 2009 · 972 citations · Full text